The Douglas Pharmaceuticals Innovation Building is Douglas’s most ambitious development yet and sets the scene for future growth in their business.  The new Research and Development building, which is linked to existing warehouse and offices, will house 120 people over three stories with the focus in leading the development and registration of specialty generic medicines for US, EU and global markets.

A key feature of the proposed building is the ‘skybridge’, a dynamic form which functions as both internal access between buildings and screens the old warehouse behind. The external façade consists primarily of glass and solid aluminum panel through a fully unitized Thermosash curtain wall system, providing for efficient construction and high-quality finish of the external fabric.

The 4,500m² building was completed in 2021 and is the largest pharmaceutical research and development facility in New Zealand and a large investment in the local economy.